Skip to main content

Paychex Is Set Up For Robust Growth In Calander 2021

Tuesday, April 6, 2021 | Thomas Hughes
Paychex Is Set Up For Robust Growth In Calander 2021

Paychex Q3 Earnings Do Not Include March Results 

Considering the strength of the March NFP report we really thought Paychex (NASDAQ: PAYX) would have reported a better quarter. In hindsight, though, that expectation was misplaced because the Paychex Q3 period ended in February and well before the March surge in hiring began. Even the KC Fed’s Labor Market Conditions Index failed to capture the strength, so much so that it included a statement to the effect the February read does not reflect the current state of labor market conditions. 

“These readings likely do not fully describe the state of the labor market at the end of February, as many of the input data series reflect conditions early in the month. In particular, the series does not include the effects of the decrease in new COVID-19 cases or the acceleration in vaccine administration that occurred later in the month ... Therefore, labor market developments in the latter half of February, including the labor market response to recent COVID-19 developments, will likely show up in the March 2021 LMCI readings.”

The takeaway here is simple. Paychex Q3 results weren’t as strong as we thought they could be but Q4 surely will. Hiring has picked up strength and, based on the company’s internal metrics, that strength is going to result in highly leverage revenue and earnings growth the analysts have yet to factor in. In our view, this company is not only set up to beat the consensus but by such a wide margin it will impact the consensus estimates for next year and the year after as well. That situation will drive share prices higher over the long term. 

Paychex Revenue In-Line, Earnings Beat 

Paychex’s 3rd quarter revenue grew sequentially for the 4th quarter to $1.11 billion. This is shy of the YOY comparison by 2.6% but this is the last quarter of hard comps. Not only do we expect the next quarter’s revenue to accelerate sequentially again but the comp to last year is against the calendar Q2 period when shut-downs were at their worst. 

The details we like most show that revenue is down due to a decrease in spending per client associated with smaller workforces and not because of client loss. Regarding client loss, the company says retention is strong and that its client base has actually grown in the last year. In this scenario, coupled with an increase in the number of services offered, the March 2021 wave of hiring should produce accelerating revenue growth in the 4th quarter and revenue above well above the pre-COVID level. 

Moving down, the company was able to reduce and control its expenses over the past year and quarter. This led to a 4% improvement in SG&A expenses and a 1.1% increase in Operating Income. On the bottom line, the improvement in margin can be seen in both the GAAP and adjusted earnings. GAAP EPS of $0.97 beat by a nickel while the adjusted $0.96 beat by $0.04. 

Paychex Dividend Is Attractive And Safe 

Paychex pays an attractively high-yielding dividend that is much safe than it may appear. At face value, the company is paying out 85% of its earnings which is a bit high but there is this to consider. The company has very little debt, more than enough cash to pay it all off, ultra-low leverage, a high coverage ratio, ample FCF, and growing earnings. In our view, this dividend is as safe as they come and one that may see an unexpected increase in the not-too-distant future. 

Shares of Paychex are down -5.0% following the Q3 release and we think this is a knee-jerk reaction to some news that should have been expected. In that light, the stock is offering a potential entry point for new money but we suggest waiting for support to confirm before buying in. The best first target for support is near the $92 level, if that is breached a move to $88 may be in the cards.

Paychex Is Set Up For Robust Growth In Calander 2021

Featured Article: Penny Stocks, What You Need To Know


7 Hotel Stocks Just Waiting For the Vaccine

Like any group of stocks related to travel and tourism, hotel stocks saw a steep drop in share prices in 2020. The leisure and hospitality sector that once had 15 million employees has lost 4 million jobs since February.

Many major cities will be feeling the ripple effects of the Covid-19 pandemic for years. However, there is ample evidence that shows the pandemic may be coming to an end. The number of new cases is dropping. The number of those getting vaccinated is rising. And even in the cities with the most restrictive mitigation measures, the slow process of reopening is beginning.

All of this can’t come fast enough for individuals who rely on the travel and tourism industry for their livelihood. Hotel chains had at least some revenue coming in the door. And when earnings season concludes, the more budget-friendly hotel chains may realize revenue that is 75% of its 2019 numbers. But that is not enough to bring the hotels to anywhere near full employment. Particularly with hotels that have bars and restaurants that have remained closed or open at limited capacity.

Many economists are optimistic that travel may begin to look more normal by the summer of this year. And the global economy may deliver 6.4% GDP growth this year. With that in mind, the hotel chains with the best fundamentals and the broadest footprint will be in the best position as the economy reopens.

View the "7 Hotel Stocks Just Waiting For the Vaccine".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Paychex (PAYX)1.5$100.01+1.5%2.64%34.13Hold$93.00
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.